1/ CDC ART data: after ~35, embryo transfer success rates between donor eggs and native eggs diverge. With a patient’s own eggs, live-birth per transfer falls sharply; donor-egg rates hold ~40–45% into the mid-40s.
credit: @RuxandraTeslo
Congratulations to U-Ploid Biotechnologies winner of the Technology Excellence Award, sponsored by @TeamGravita at the 2026 Oxfordshire Business Awards 🏆
4/ At U-Ploid we’re developing treatments to restore function in older eggs and raise euploid embryo yield. If you’re working on next-gen repro tech, let’s connect.
1/ CDC ART data: after ~35, embryo transfer success rates between donor eggs and native eggs diverge. With a patient’s own eggs, live-birth per transfer falls sharply; donor-egg rates hold ~40–45% into the mid-40s.
credit: @RuxandraTeslo
3/ Today’s options for women of advanced maternal age are limited: donor eggs, adoption or turn back time to freeze eggs during peak reproductive years!
10/ Follow for charts, trial design threads, and the front line of reproductive medicine. If this resonates, amplify and tag someone who cares about making IVF reliably work.
1/ Fertility is our future. If we want support more people to build families, we have to make IVF work better by fixing upstream biology, not just adding more downstream steps/ apps/ costs. 👇
😍It was an absolute delight to have U-Ploid Biotechnologies on our last cohort of Accelerate@Babraham.
🌟The co-founders really made the most of the opportunity and we're thrilled to read Alexandre's endorsement.
Find out how to apply for 2025 👇 https://t.co/ydjTrbYGTm
Europe's baby boom is over! 👶📉 Record low birth rates signal a major shift in parenthood, with couples increasingly having children later in life. What should we be doing to better support would-be parents? 🤔 #parenthood#demographics#lateparenthood
Here’s to solving the big problems that matter.
Huge kudos to our Fellows turned Founders, @Jordan_Abdi, Chloe Charalambous, & @AlexandreWebst3 for officially launching U-Ploid Biotech, addressing the global challenge of age-related infertility through a breakthrough platform..